Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by saveyourselfnowon Aug 14, 2018 10:54am
69 Views
Post# 28456742

RE: The long term benefit of Ontario's delay.

RE: The long term benefit of Ontario's delay.
Daredevil1964 wrote: NOW THE GOOD SIDE OF THIS DELAY. 

Ontario delaying the launch of private marijuana sales in brick-and-mortar stores until April 2019 is a near-term negative, but a longer-term positive for the sector, analysts say.
  • Canaccord analyst Matt Bottomley sees the delays as short-term drag but a potential long-term net positive; if Canadian licensed-producers (LP) are included in the private retail model, there is potential for LPs to achieve higher margins as they could significantly benefit from retail selling prices in a more vertically integrated market
  • GMP analyst Martin Landry thinks this will be a near-term headwind for cannabis retail sales as a physical retail network is essential to capture a meaningful share of black-market
    • However, Landry expects private retail to be more effective than a government monopoly to capture market share from black-market
    • Highlights Cronos Group, Canopy Growth and Aurora Cannabis among winners in this backdrop
  • Eight Capital analyst Graeme Kreindler says a privatized system seems to be positive for the cannabis industry and its ability to diminish the illicit market; sees the ability to provide a safe, welcoming and accessible retail environment as a key element for the Canadian market to reach its full estimated potential of C$11b
    • However, he isn’t changing any valuation for the stocks under coverage until there is more clarity on issues such as number of retail licenses to be issued, caps on license ownership, LP involvement in retail, etc


awwwwwww stick to your daily house postitions post

how did that data help you or anyone else?

sheeeeeeeeeeesh

d r o p   d e a d

or jump over the Ceasar's Palace fountains on your skateboard!
Bullboard Posts